Internal Medicine · Sherman Oaks, CA
NPI
1497807853
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
4955 Van Nuys Blvd Ste 308
Sherman Oaks, CA, 91403
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
25,871 services
Medicare patients, 2024
1,693
Average age 74
Drug cost, 2024
$2.1M
26,517 prescriptions
Company payments, 2025
$20.4
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Keino A Rutherford was code 99308 (snf e&m), 9,900 times for 711 patients. In total Keino A Rutherford billed 25,871 services in 28 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 9,900 | 711 | $60.36 | $598K |
| 99487 Chronic, Principal, and Transitional Care Management | Facility | 4,091 | 846 | $70.28 | $288K |
| 99309 SNF E&M | Facility | 3,935 | 744 | $89.58 | $352K |
| 99233 Hospital E&M - Subsequent | Facility | 1,483 | 525 | $96.51 | $143K |
| 99497 Care Management/Coordination | Facility | 1,275 | 1,057 | $61.65 | $79K |
| 99306 SNF E&M | Facility | 1,261 | 841 | $148.46 | $187K |
| 99232 Hospital E&M - Subsequent | Facility | 765 | 219 | $64.40 | $49K |
| 99483 Office/Outpatient Services | Facility | 655 | 643 | $158.45 | $104K |
| 99310 SNF E&M | Facility | 641 | 399 | $127.54 | $82K |
| 99316 SNF E&M | Facility | 472 | 441 | $107.42 | $51K |
| 99239 Hospital Discharge Management | Facility | 453 | 424 | $94.33 | $43K |
| 99223 Hospital E&M - Initial | Facility | 422 | 401 | $140.94 | $59K |
| 99291 Critical Care E&M | Facility | 317 | 84 | $172.20 | $55K |
| 99348 Home E&M - New and Established | Office | 72 | 44 | $60.97 | $4,390 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 57 | 50 | $42.56 | $2,426 |
By year: 2022 $1.5M for 18,764 services; 2023 $2.0M for 23,375 services; 2024 $2.1M for 25,871 services.
Medicare prescription drug claims, 2024
In 2024, the drug Keino A Rutherford prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,300 prescriptions and refills. In total Keino A Rutherford wrote 26,517 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,300 | 1,330 | 246 | $16K |
| Divalproex Sodium Generic | 889 | 903 | 138 | $41K |
| Levothyroxine Sodium Generic | 854 | 863 | 109 | $7,290 |
| Olanzapine Generic | 771 | 785 | 119 | $15K |
| Amlodipine Besylate Generic | 701 | 712 | 119 | $5,111 |
| Metformin Hcl Generic | 674 | 707 | 108 | $5,967 |
| Gabapentin Generic | 650 | 660 | 126 | $8,161 |
| Pantoprazole Sodium Generic | 643 | 655 | 140 | $30K |
| Risperidone Generic | 570 | 581 | 91 | $7,861 |
| Eliquis Apixaban | 557 | 558 | 76 | $171K |
| Famotidine Generic | 522 | 542 | 98 | $5,019 |
| Tamsulosin Hcl Generic | 485 | 502 | 84 | $6,185 |
| Quetiapine Fumarate Generic | 466 | 473 | 91 | $8,563 |
| Metoprolol Tartrate Generic | 442 | 449 | 86 | $3,561 |
| Furosemide Generic | 398 | 410 | 73 | $2,099 |
Brand drugs: 3,933 claims; generic drugs: 22,469 claims; opioid claims: 575.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Keino A Rutherford $20.4 ($20.4 in general payments such as food, travel and fees) from 1 company. The largest payer was Otsuka America Pharmaceutical, Inc. with $20.4.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $20.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.